Hagop Kantarjian, Associate Vice President for Global Academic Programs at MD Anderson Cancer Center, shared a recent article he and his colleagues co-authored on X, adding:
“There have been major advances in ALL therapy over the last decade.
Check out our review just published in the ACS Journal discussing these advances and revolution in adult ALL therapy.”
Title: The evolving therapeutic revolution in adult acute lymphoblastic leukemia
Journal: ACS
Authors: Hagop Kantarjian, Nitin Jain, Mark R. Litzow, Selina M. Luger, Cristina Papayannidis, Josep-Maria Ribera, Nicholas J. Short, Helen T. Chifotides, Elias Jabbour
More posts featuring Hagop Kantarjian on OncoDaily.